AR213705A1 - Procedimiento para preparar(2-imidazolin-2-ilamino)-quinolinas,quinoxalinas y-quinazolinas sustituidas - Google Patents
Procedimiento para preparar(2-imidazolin-2-ilamino)-quinolinas,quinoxalinas y-quinazolinas sustituidasInfo
- Publication number
- AR213705A1 AR213705A1 AR246774A AR24677473A AR213705A1 AR 213705 A1 AR213705 A1 AR 213705A1 AR 246774 A AR246774 A AR 246774A AR 24677473 A AR24677473 A AR 24677473A AR 213705 A1 AR213705 A1 AR 213705A1
- Authority
- AR
- Argentina
- Prior art keywords
- ilamine
- quinoxalines
- quinazolines
- imidazolin
- quinolines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/40—Nitrogen atoms attached in position 8
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/42—Benzopyrazines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB919672A GB1381979A (en) | 1972-02-29 | 1972-02-29 | Amino derivatives of quinoline quinoxaline and quinazoline |
GB5162972 | 1972-11-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR213705A1 true AR213705A1 (es) | 1979-03-15 |
Family
ID=26242776
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AR246774A AR213705A1 (es) | 1972-02-29 | 1973-02-23 | Procedimiento para preparar(2-imidazolin-2-ilamino)-quinolinas,quinoxalinas y-quinazolinas sustituidas |
Country Status (16)
Country | Link |
---|---|
US (1) | US3890319A (fr) |
JP (2) | JPS5754516B2 (fr) |
AR (1) | AR213705A1 (fr) |
AU (1) | AU471598B2 (fr) |
BE (1) | BE795970A (fr) |
CA (1) | CA981678A (fr) |
CH (2) | CH577500A5 (fr) |
DE (1) | DE2309160A1 (fr) |
ES (2) | ES411804A1 (fr) |
FI (1) | FI63757C (fr) |
FR (1) | FR2181776B1 (fr) |
GB (1) | GB1381979A (fr) |
IE (1) | IE37519B1 (fr) |
MX (1) | MX3042E (fr) |
NL (1) | NL159102B (fr) |
SE (1) | SE417204B (fr) |
Families Citing this family (84)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1463520A (en) * | 1974-09-06 | 1977-02-02 | Pfizer Ltd | Process for the production of imidazolines |
JPS5373571A (en) * | 1976-12-10 | 1978-06-30 | Otsuka Pharmaceut Co Ltd | Carbostyril derivatives |
JPS542338A (en) | 1977-04-22 | 1979-01-09 | Sandoz Ag | Pharmaceutical composition |
US4188393A (en) | 1977-04-22 | 1980-02-12 | Sandoz Ltd. | Treating spastic conditions or relaxing muscles |
FR2449087A2 (fr) * | 1979-02-16 | 1980-09-12 | Rhone Poulenc Ind | Nouveaux derives de l'isoquinoleine, leur preparation et les compositions pharmaceutiques qui les contiennent |
US4486432A (en) * | 1982-09-30 | 1984-12-04 | Eli Lilly And Company | Quinoxalinedione leukotriene release inhibitors |
FR2541680B1 (fr) * | 1983-02-24 | 1985-06-14 | Rhone Poulenc Sante | Nouveaux derives de l'amino-5 dithiole-1,2 one-3, leur preparation et les compositions medicinales qui les contiennent |
JPS6118950U (ja) * | 1984-07-10 | 1986-02-03 | 財団法人鉄道総合技術研究所 | トロリ線の給油装置 |
JPS63296814A (ja) * | 1987-05-29 | 1988-12-02 | Ishigaki Kiko Kk | 集塵装置における濾材の目詰り除去装置 |
GB8827820D0 (en) * | 1988-11-29 | 1988-12-29 | Janssen Pharmaceutica Nv | (1h-azol-1-ylmethyl)substituted quinoline derivatives |
US5180721A (en) * | 1989-05-22 | 1993-01-19 | Allergan, Inc. | Combinations of selective alpha-adrenergic agonists and antagonists useful in lowering intraocular pressure |
US5281591A (en) * | 1989-05-22 | 1994-01-25 | Allergan, Inc. | Combinations of selective alpha-adrenergic agonists and antagonists useful in lowering intraocular pressure |
US5231096A (en) * | 1989-10-12 | 1993-07-27 | Allergan, Inc. | Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
US5077292A (en) * | 1989-10-12 | 1991-12-31 | Allergan, Inc. | (2-imidazolin-2-ylamino) tetrahydroquinoxalines and methods for using same |
US5326763A (en) * | 1989-10-12 | 1994-07-05 | Allergan, Inc. | Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
US5112822A (en) * | 1989-10-12 | 1992-05-12 | Allergan, Inc. | (2-imidazolin-2-ylamino) quinoxaline derivatives and methods for using same |
US5198442A (en) * | 1989-10-12 | 1993-03-30 | Allergan, Inc. | (2-imidazolin-2-ylamino) quinoxaline derivatives and methods for using same |
US5204347A (en) * | 1989-10-12 | 1993-04-20 | Allergan, Inc. | Methods for using (2-imidazolin-2-ylamino) tetrahydroquinoxalines |
US5021416A (en) * | 1989-10-31 | 1991-06-04 | Allergan, Inc. | Method for using (2-imidazolin-2-ylamino) quinoxalines to reduce or maintain intraocular pressure |
US5215991A (en) * | 1990-01-26 | 1993-06-01 | Allergan, Inc. | Combination of selective alpha-adrenergic agonists and Na+ /H+ ex |
US5237072A (en) * | 1990-02-06 | 1993-08-17 | Allergan, Inc. | Method for producing amino-2-imidazoline derivatives |
US5130441A (en) * | 1990-02-06 | 1992-07-14 | Allergan, Inc. | Method for producing amino-2-imidazoline derivatives |
US5252595A (en) * | 1990-02-28 | 1993-10-12 | Allergan, Inc. | Method for reducing or maintaining intraocular pressure in the mammalian eye by administering pharmaceutical compositions containing 2-(2-alkylphenylamino)-oxazolines, 2-(2-alkylphenylamino)-thiazolines and 2-(2-alkylphenylamino)-imidazolines |
US5091528A (en) * | 1990-09-12 | 1992-02-25 | Allergan, Inc. | 6- or 7- (2-imino-2-imidazolidine)-1,4-benzoxazines as α adrenergic agents |
ES2187533T3 (es) * | 1993-10-13 | 2003-06-16 | Allergan Inc | Usdo de derivados de (2-imidazolin-2-ilamino)quinoxalina. |
US6323204B1 (en) * | 1993-10-13 | 2001-11-27 | Allergan | Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
US5580892A (en) * | 1993-10-22 | 1996-12-03 | Allergan | Method for using 2-(2-alkylphenylamino)-oxazolines as adrenergic agents |
US5578607A (en) * | 1993-12-17 | 1996-11-26 | The Procter & Gamble Company | 6-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists |
US5478858A (en) * | 1993-12-17 | 1995-12-26 | The Procter & Gamble Company | 5-(2-imidazolinylamino) benzimidazole compounds useful as alpha-2 adrenoceptor agonists |
HU217841B (hu) * | 1993-12-17 | 2000-04-28 | The Procter & Gamble Co. | 6-[(2-Imidazolidinilidén)-amino]-kinolin-származékok és ezeket tartalmazó gyógyszerkészítmények |
US5576437A (en) * | 1993-12-17 | 1996-11-19 | The Procter & Gamble Company | 7-(2-imidazolnylamino) quinoline compounds useful as alpha-2 adrenoceptor agonists |
JPH09506622A (ja) * | 1993-12-17 | 1997-06-30 | ザ、プロクター、エンド、ギャンブル、カンパニー | α−2−アドレノセプター作動剤として有用な6−(2−イミダゾリニルアミノ)キノキサリン化合物 |
DK0693055T3 (da) * | 1994-02-08 | 1997-12-15 | Alcon Lab Inc | Hidtil ukendt fremgangsmåde til fremstilling af clonidinderivater |
WO1996004270A1 (fr) | 1994-08-04 | 1996-02-15 | Synaptic Pharmaceutical Corporation | Nouveaux derives de benzimidazole |
US6294563B1 (en) | 1994-10-27 | 2001-09-25 | Allergan Sales, Inc. | Combinations of prostaglandins and brimonidine or derivatives thereof |
US6194415B1 (en) | 1995-06-28 | 2001-02-27 | Allergan Sales, Inc. | Method of using (2-imidazolin-2-ylamino) quinoxoalines in treating neural injury |
US5916900A (en) * | 1995-06-29 | 1999-06-29 | The Procter & Gamble Company | 7-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists |
US6172095B1 (en) | 1996-11-25 | 2001-01-09 | The Procter & Gamble Company | Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists |
HUP9904215A3 (en) * | 1996-11-25 | 2002-01-28 | Procter & Gamble | 2-imidazolinylaminoindole compounds useful as alpha-2 adrenoceptor agonists |
WO1998023596A1 (fr) | 1996-11-25 | 1998-06-04 | The Procter & Gamble Company | Composes guanidinyl heterocycles convenant comme agonistes de l'adrenorecepteur alpha-2 |
AU5433898A (en) * | 1996-11-25 | 1998-06-22 | Procter & Gamble Company, The | 2-imidazolinylaminobenzothiazole compounds useful as alpha-2 adrenoceptor agonists |
US6306877B1 (en) | 1999-08-09 | 2001-10-23 | The Procter & Gamble Co. | Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists |
TR199901486T2 (xx) * | 1996-11-25 | 1999-10-21 | The Procter & Gamble Company | Alfa-2 adrenosept�r agonistleri olarak yararl� 2-imidazolinilamino-benzoksazol bile�ikleri. |
US6495583B1 (en) | 1997-03-25 | 2002-12-17 | Synaptic Pharmaceutical Corporation | Benzimidazole derivatives |
WO1999026942A1 (fr) | 1997-11-24 | 1999-06-03 | The Procter & Gamble Company | 5-(2-imidazolinylamino)-benzimidazole, derives et procedes de preparation et d'utilisation de ces derniers en tant qu'agonistes du recepteur alpha-adrenergique ayant une meilleure stabilite metabolique |
US6242442B1 (en) | 1998-12-17 | 2001-06-05 | Alcon Laboratories, Inc. | Brinzolamide and brimonidine for treating ocular conditions |
US20050026924A1 (en) * | 2000-07-14 | 2005-02-03 | Allergan, Inc. | Compositions containing alpha-2-adrenergic agonist components |
US8858961B2 (en) * | 2000-07-14 | 2014-10-14 | Allergan, Inc. | Compositions containing alpha-2-adrenergic agonist components |
MXPA02012206A (es) | 2000-07-14 | 2003-06-04 | Allergan Inc | Composiciones que contienen componentes terapeuticamente activos que tienen solubilidad mejorada. |
US20040214829A1 (en) * | 2000-07-14 | 2004-10-28 | Allergan, Inc. | Compositions containing alpha-2-adrenergic agonist components |
CA2402405C (fr) | 2000-07-14 | 2008-02-12 | Allergan Sales, Inc. | Compositions contenant des composants agonistes alpha-2 adrenergiques |
DE10161767A1 (de) * | 2001-12-15 | 2003-06-26 | Merck Patent Gmbh | 2-Guanidino-4-heterocyclyl-chinazoline |
US7642258B2 (en) * | 2002-04-19 | 2010-01-05 | Allergan, Inc. | Combination of brimonidine and timolol for topical ophthalmic use |
US7030149B2 (en) | 2002-04-19 | 2006-04-18 | Allergan, Inc. | Combination of brimonidine timolol for topical ophthalmic use |
RU2330649C2 (ru) * | 2002-10-08 | 2008-08-10 | Аллерган, Инк. | Агонисты альфа-2в или 2в/2с адренорецепторов для лечения нейродегенеративных заболеваний |
US20040116436A1 (en) * | 2002-10-08 | 2004-06-17 | Tatton William G. | Treatment of dementia and parkinson's disease |
US20040191332A1 (en) * | 2003-03-27 | 2004-09-30 | Allergan, Inc. | Preserved ophthalmic compositions |
US8410102B2 (en) | 2003-05-27 | 2013-04-02 | Galderma Laboratories Inc. | Methods and compositions for treating or preventing erythema |
US7439241B2 (en) | 2003-05-27 | 2008-10-21 | Galderma Laboratories, Inc. | Compounds, formulations, and methods for treating or preventing rosacea |
ATE444732T1 (de) | 2003-08-07 | 2009-10-15 | Allergan Inc | Zusammensetzungen zur abgabe von therapeutika in die augen und verfahren zu ihrer herstellung und verwendung |
CA2535614C (fr) * | 2003-08-14 | 2009-12-22 | Array Biopharma Inc. | Analogues de quinazoline comme inhibiteurs du recepteur de la tyrosine kinase |
US7501427B2 (en) | 2003-08-14 | 2009-03-10 | Array Biopharma, Inc. | Quinazoline analogs as receptor tyrosine kinase inhibitors |
US20070042951A1 (en) * | 2003-10-08 | 2007-02-22 | Allergan, Inc. | Pharmaceutical compositions comprising alpha-2-adrenergics and trefoil factor family peptides |
JP4955543B2 (ja) | 2004-05-25 | 2012-06-20 | サンズローザ ファーマシューティカル ディヴェロップメント インコーポレイテッド | 炎症性皮膚疾患を治療又は予防するための化合物、製剤及び方法 |
US7534795B2 (en) * | 2005-10-25 | 2009-05-19 | Allergan, Inc. | Compounds and their use related to compositions for treating disease |
ZA200804550B (en) | 2005-11-09 | 2009-08-26 | Combinatorx Inc | Methods, compositions, and kits for the treatment of medical conditions |
PL1971601T3 (pl) * | 2005-11-15 | 2010-03-31 | Array Biopharma Inc | Pochodne N4-fenylo-chinazolino-4-aminy i związki pokrewne jako inhibitory receptorowych kinaz tyrozynowych ErbB typu I do leczenia chorób cechujących się nadmierną proliferacją komórek |
WO2008074068A1 (fr) * | 2006-12-20 | 2008-06-26 | Prana Biotechnology Limited | Dérivés de quinoline substitués utilisés comme agents non-amyloïdogéniques |
US20080293728A1 (en) * | 2007-05-18 | 2008-11-27 | Mcintire Gregory L | Complexes Comprising alpha2-Adrenergic Receptor Agonists and Compositions |
US9192571B2 (en) * | 2008-03-03 | 2015-11-24 | Allergan, Inc. | Ketorolac tromethamine compositions for treating or preventing ocular pain |
US7842714B2 (en) * | 2008-03-03 | 2010-11-30 | Allergan, Inc. | Ketorolac tromethamine compositions for treating ocular pain |
CA2777223C (fr) | 2009-10-06 | 2017-10-24 | Allergan, Inc. | Derives de 2h-pyrrol-5-amine utilises en tant que modulateurs des recepteurs alpha-adrenergiques |
EP2329849B1 (fr) | 2009-11-18 | 2015-04-29 | Galderma Research & Development | Combinaison d'un agoniste du récepteur alpha-2 adrénergique et d'un agent anti-inflammatoire non stéroïdien pour traiter ou empêcher un trouble cutané inflammatoire |
US8394800B2 (en) | 2009-11-19 | 2013-03-12 | Galderma Laboratories, L.P. | Method for treating psoriasis |
US9522153B2 (en) | 2009-12-22 | 2016-12-20 | Allergan, Inc. | Compositions and methods for lowering intraocular pressure |
BR112012024289A2 (pt) | 2010-03-26 | 2017-07-18 | Galderma Res & Dev | "método para fornecer um tratamento seguro e efetivo do eritema e composição de gel tópica" |
KR20130010122A (ko) | 2010-03-26 | 2013-01-25 | 갈데르마 리써어치 앤드 디벨로프먼트 | 모세혈관 확장증의 안전하고 유효한 치료를 위한 개선된 방법 및 조성물 |
AU2011237677A1 (en) | 2010-04-07 | 2012-11-08 | Allergan, Inc. | Combinations of preservative compositions for ophthalmic formulations |
AU2011237689A1 (en) | 2010-04-07 | 2012-11-08 | Allergan, Inc. | Combinations of preservatives for ophthalmic compositions |
CA2807084C (fr) | 2010-07-29 | 2018-05-22 | Allergan, Inc. | Solutions de brimonidine et de timolol sans conservateur |
US8053427B1 (en) | 2010-10-21 | 2011-11-08 | Galderma R&D SNC | Brimonidine gel composition |
ES2498217T5 (es) | 2010-10-21 | 2018-03-19 | Galderma S.A. | Composición en forma de gel basada en brimonidina |
KR20140062471A (ko) | 2011-07-25 | 2014-05-23 | 알러간, 인코포레이티드 | 알파 2 아드레날린 수용체의 조절물질로서의 n-(이미다졸리딘-2-일리덴)퀴놀린 유도체 |
GR1009419B (el) | 2017-11-07 | 2018-12-14 | Φαρματεν Αβεε | Οφθαλμικο φαρμακευτικο σκευασμα που περιεχει εναν συνδυασμο βρινζολαμιδης και βριμονιδινης και μεθοδος για την παρασκευη αυτου |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3560501A (en) * | 1966-09-15 | 1971-02-02 | Ciba Geigy Corp | Process for making dihydroquinazolines |
US3594380A (en) * | 1969-02-18 | 1971-07-20 | American Home Prod | Isoquinolin-1(2h)-ones |
BE766039A (fr) * | 1971-04-21 | 1971-09-16 | Labofina Sa | Nouveaux polymeres contenant des unites de pyrazole et procede de preparation de ces polymeres. |
-
0
- BE BE795970D patent/BE795970A/fr not_active IP Right Cessation
-
1972
- 1972-02-29 GB GB919672A patent/GB1381979A/en not_active Expired
-
1973
- 1973-02-08 AU AU51985/73A patent/AU471598B2/en not_active Expired
- 1973-02-13 SE SE7302024A patent/SE417204B/xx unknown
- 1973-02-14 US US332485A patent/US3890319A/en not_active Expired - Lifetime
- 1973-02-14 IE IE236/73A patent/IE37519B1/xx unknown
- 1973-02-14 FI FI436/73A patent/FI63757C/fi active
- 1973-02-15 MX MX129473U patent/MX3042E/es unknown
- 1973-02-20 ES ES411804A patent/ES411804A1/es not_active Expired
- 1973-02-21 JP JP48020280A patent/JPS5754516B2/ja not_active Expired
- 1973-02-22 CA CA164,361A patent/CA981678A/en not_active Expired
- 1973-02-23 AR AR246774A patent/AR213705A1/es active
- 1973-02-23 DE DE19732309160 patent/DE2309160A1/de active Pending
- 1973-02-27 ES ES412102A patent/ES412102A1/es not_active Expired
- 1973-02-28 NL NL7302799.A patent/NL159102B/xx not_active IP Right Cessation
- 1973-02-28 FR FR7307157A patent/FR2181776B1/fr not_active Expired
- 1973-02-28 CH CH149075A patent/CH577500A5/xx not_active IP Right Cessation
- 1973-02-28 CH CH293873A patent/CH576975A5/xx not_active IP Right Cessation
-
1980
- 1980-07-11 JP JP9493480A patent/JPS5625176A/ja active Granted
Also Published As
Publication number | Publication date |
---|---|
IE37519B1 (en) | 1977-08-17 |
CH577500A5 (fr) | 1976-07-15 |
JPS5745439B2 (fr) | 1982-09-28 |
AU5198573A (en) | 1974-08-08 |
JPS5754516B2 (fr) | 1982-11-18 |
JPS4897878A (fr) | 1973-12-13 |
US3890319A (en) | 1975-06-17 |
DE2309160A1 (de) | 1973-09-27 |
CH576975A5 (fr) | 1976-06-30 |
AU471598B2 (en) | 1976-04-29 |
CA981678A (en) | 1976-01-13 |
NL159102B (nl) | 1979-01-15 |
FR2181776A1 (fr) | 1973-12-07 |
ES412102A1 (es) | 1976-05-16 |
BE795970A (fr) | 1973-08-27 |
IE37519L (en) | 1973-08-29 |
FI63757B (fi) | 1983-04-29 |
JPS5625176A (en) | 1981-03-10 |
FR2181776B1 (fr) | 1976-08-13 |
ES411804A1 (es) | 1976-05-01 |
FI63757C (fi) | 1983-08-10 |
SE417204B (sv) | 1981-03-02 |
GB1381979A (en) | 1975-01-29 |
NL7302799A (fr) | 1973-08-31 |
MX3042E (es) | 1980-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR213705A1 (es) | Procedimiento para preparar(2-imidazolin-2-ilamino)-quinolinas,quinoxalinas y-quinazolinas sustituidas | |
ES188038Y (es) | Muneca y similares. | |
AR203373A1 (es) | Procedimiento para preparar 4-amino-quinazolinas | |
AR198515A1 (es) | Nuevos pigmentos bis-azometinicos, procedimiento para prepararlos y empleo de ellos | |
AR193637A1 (es) | Procedimiento para preparar compuestos de 3-metilencefalosporina y nuevos compuestos resultantes del mismo | |
TR17513A (tr) | Fenilindol tuerevleri,bunlarin imali usulue,ve kullanilmalari | |
BR7307487D0 (pt) | Adsorvente e processo para obtencao do mesmo | |
AR207946A1 (es) | Procedimiento para preparar 2-amino-metilenindanona | |
BR7307461D0 (pt) | Rido-(4-3-d)-pirimidin-4-(3h)-onas 2 substituidas, e proceprocesso para preparar pirido-(2-3-d), piripo-(3-4-d) e pisso para preparar amino-nicotino-nitrilas | |
AR206887A1 (es) | Procedimiento para preparar nuevos d-2-halo-6-metil-8-cianometilergolinas | |
IT983165B (it) | Fungicidi pirimidinici loro pro duzione e loro impiego | |
AR197410A1 (es) | Colorantes tiofen-1-azoicos y procedimiento para prepararlos | |
AR202184A1 (es) | Compuestos 1,4-bis-imino-isoindolinona-fenileno y procedimiento para prepararlos | |
AR197057A1 (es) | Procedimiento para preparar 1- arilidenamino-4- (2 - oxo -3 - fenil - 3 - benzofuril) piperacinas | |
AR200718A1 (es) | Procedimiento para preparar 1-isopropil-4-fenil-7-metil-2(1h)-quinazolinona | |
AR196038A1 (es) | Nuevos acidos naftalimid-4,5-dicarboxilicos y procedimiento para su preparacion | |
ES216391Y (es) | Cuenca para piacinas y similares. | |
AR196443A1 (es) | Procedimiento para preparar 1-2-bromo-2,2-difluociclopropano | |
AR200994A1 (es) | Procedimiento para preparar 3-fluor-d-alanina y su deuteroanalogo | |
AR203651A1 (es) | Procedimiento para preparar feniltiometil y feniloximetil-6,7-dihidroxi-1,2,3,4,-tetrahidroisoquinolinas | |
AR195800A1 (es) | Herbicidas isotiazolopirimidinicos y procedimiento para prepararlos | |
AR203848A1 (es) | Procedimiento para preparar feniltiometil y feniloximetil-6,7-dihidroxi-1,2,3,4-tetrahidro-isoquinolinas | |
AR204232A1 (es) | Procedimiento para preparar derivados 1,3,4,5-tetrahidro-2,3-benzoxazepinicos | |
DOP1971001775A (es) | Antibiotico 67-694 y procedimiento para producirlo. | |
AR197349A1 (es) | Difenilpirazolinas y procedimiento para obtenerlas |